×

Nick Plessas Joins Inolife Technologies, Inc. Executive Team as V.P. of Business Development

RALEIGH, N.C., June 11, 2013 (GLOBE NEWSWIRE) -- Inolife Technologies, Inc. (OTCBB:INOL), a diversified service-based healthcare and environmental product developer and marketer is pleased to announce the company has hired Mr. Nick Plessas as its V.P. of Business Development.

The company's CEO, Mr. Gary Berthold, states, "The addition of Mr. Plessas to the management team is important and is in keeping with its execution of the growth strategy. Mr. Plessas brings more than 25 years of experience in developing and marketing environmental solutions to the commercial and retail markets."

With strong expansion and development plans in place for 2013-2014, the Company has recruited Mr. Plessas to serve as a senior member of the management team to lead the areas of retail business development and new ventures. Mr. Plessas will be responsible to research, identify, analyze and recommend specific business opportunities for the profitable growth in the retail sector, including identifying alliance partners, joint ventures, acquisitions and mergers.

Since having completed the curriculum of Masters Environmental Studies (M.E.S) program in 1980, Mr. Plessas has pioneered many leading edge, safe, effective and sustainable products by applying dynamic chemistry and nano-technology. With over 10 years of international experience, he possesses a strong understanding of customer and market dynamics and requirements.

Mr. Plessas' immediate focus will be centered on the all natural skin care line for women and men's healthcare products. Inolife will combine patented compounds with all natural ingredients providing a healthcare and skincare product line with Anti-Aging beneficial properties.

About Inolife Technologies, Inc.

Inolife Technologies, Inc. is organized to develop and market DNA Testing products within the US. The Company's mission is to aggressively identify, manufacture and market innovative and affordable healthcare products and services directly to the marketplace. By targeting cutting-edge DNA-based testing and reporting methodologies, the company is able to significantly benefit the health and wellness needs of both individuals and their healthcare providers.

Inolife Technologies, Inc. markets the commercial use of proprietary Intellectual Property by manufacturing, brand marketing and selling an integrated program of age reversing creams and lotions. These products will be sold directly to consumers through e-commerce, direct sales, pharmacies, retailers, distributors and healthcare providers. It also offers products that are sold only to physicians, hospitals, outpatient facilities and others in the medical community for use with their patients.

Forward-Looking Statements: Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.

CONTACT: Henry Harrison Harrison, Elliott & Brown, LLC 407-350-0146 Henry@insidewallstreet.comSource:Inolife Technologies, Inc.